Aspen Pharmacare to list on A2X

Aspen Pharmacare Holdings [JSE:APN] is set to become the latest South African company to list on the A2X Markets exchange.

The multinational pharmaceutical company will list on April 1.

A2X, which has been active since October 2017, is a licensed stock exchange which provides secondary listings for SA companies. A total of 17 companies have been listed on the exchange, including heavy hitters Naspers, the Standard Bank Group and Sanlam.  


Stephen Saad, Aspen group chief executive, said in a statement that the complementary A2X listing offered investors "trading benefits while simultaneously providing the prospect of increasing our shareholder base".

"We will retain our primary listing on the Johannesburg Stock Exchange and our issued share capital will be unaffected by the secondary listing,” he said.

Aspen's shares plunged earlier in the month after it published weak unaudited interim financial results for the six months ended December 31.

On Monday at 10:10 Aspen shares were trading at R92.08 a share on the JSE, about 30% down from when before the results were announced.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Rand - Dollar
15.84
+0.2%
Rand - Pound
19.79
+0.0%
Rand - Euro
16.72
+0.4%
Rand - Aus dollar
11.16
+0.2%
Rand - Yen
0.12
+0.3%
Gold
1,845.51
+0.2%
Silver
21.76
-0.7%
Palladium
1,968.00
-2.0%
Platinum
957.50
-1.0%
Brent Crude
112.04
+2.6%
Top 40
61,000
-1.2%
All Share
67,575
-1.0%
Resource 10
72,529
+1.6%
Industrial 25
72,948
-3.9%
Financial 15
15,746
+0.1%
All JSE data delayed by at least 15 minutes Iress logo
Company Snapshot